There are 21 papers on LGALS1 in aging research: 4 observational studies in people, 10 in animals, 4 in cells, 1 review.
At a glance
The findings reach people, from one lab or study. 6 independent labs in 3 countries.
“LGALS1 showed the strongest association with SBP (β=13.25 mm□Hg per standard deviation increase; P=7.57×10□ 1 □).”
None of its findings points the other way.
- 6 independent labs in 3 countries
- Funders: National Institutes of Health and others
- 1 of 9 findings with company ties
- Humans4
- Animals10
- Cells4
- In silico2
Interventions
1Galacto-oligosaccharides
upin mice1
1 study
Galacto-oligosaccharides
upin mice1
Galacto-oligosaccharides increase LGALS1 in mice (young mice; no effect in old mice).
Animalsyoung mice; no effect in old micedietaryshort-term
Effects
3Heart failure with preserved ejection fraction
no changein mice1
1 study
Heart failure with preserved ejection fraction
no changein mice1
LGALS1 showed no clear effect on heart failure with preserved ejection fraction in DOCA-salt-induced HFpEF mouse model.
Animalsin DOCA-salt-induced HFpEF mouse model
Senescence-associated secretory phenotype (SASP)
mediatesin mice1
1 study
Senescence-associated secretory phenotype (SASP)
mediatesin mice1
LGALS1 mediates senescence-associated secretory phenotype (SASP) in mice (MASH-HCC, tumor margin and non-tumor tissues).
AnimalsMASH-HCC, tumor margin and non-tumor tissuesliver
Cell-surface TRPV5 accumulation
mediatesin cells1
1 study
Cell-surface TRPV5 accumulation
mediatesin cells1
LGALS1 mediates cell-surface TRPV5 accumulation in cells (binding of Gal-GlcNAc exposed by Klotho-mediated sialic acid removal).
Cellsbinding of Gal-GlcNAc exposed by Klotho-mediated sialic acid removal
Upstream
2MASH-HCC
upin mice1
1 study
MASH-HCC
upin mice1
MASH-HCC induces LGALS1 in mice (MASH-HCC).
AnimalsMASH-HCCliver
Chronological aging
upin silico1
1 study
Chronological aging
upin silico1
Chronological aging increases LGALS1 in aged mouse brain.
In silicoin aged mouse brainbrain
Associations
4Sjögren's syndrome
downin humans1downin mice1
1 study
Sjögren's syndrome
downin humans1downin mice1
LGALS1 is associated with Sjögren's syndrome in humans (reduced expression in patients).
Humansreduced expression in patientssalivary gland
LGALS1 lowers the risk of Sjögren's syndrome in mice (shown by knockout in aged mice).
Animalsshown by knockout in aged micesalivary gland
Systolic blood pressure
upin humans1
1 study
Systolic blood pressure
upin humans1
LGALS1 is associated with systolic blood pressure in humans (β=13.25 mmHg per SD increase).
Humanswhole blood
CD8 immunosenescence
upin silico1
1 study
CD8 immunosenescence
upin silico1
LGALS1 predicts CD8 immunosenescence in silico (Melanoma anti-PD-1 cohort; patient-level mean per-cell score) (Mean per-cell-score AUC = 0.900; toxic-fraction-score AUC = 0.822).
In silicoMelanoma anti-PD-1 cohort; patient-level mean per-cell scoreCD8 T celln = 19
Everolimus
mixedin human cells1
1 study
Everolimus
mixedin human cells1
Everolimus is associated with LGALS1 in KMT2Ar-ALL cells.
Cellsin KMT2Ar-ALL cells